- The trend backdrop is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
CAH
BUE
Week ended 25 Sep 2026
Weekly Investor Report
Cardinal Health, Inc. · Healthcare · Medical Distribution
Latest close
118,925.00 ARS
-0.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 6.1% above the Trend Line and sits at 74.1% of its 52-week range. The latest completed week returned -0.9%, after a -5.2% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal.
Setup score
60
out of 100
Latest Close
118,925.00 ARS
25 Sep 2026
1W Return
-0.9%
latest completed week
4W Return
-5.2%
short-term follow-through
12W Return
-2.6%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- 1 reversal markers appear in the recent smart-money tape.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.9%
Latest completed week; four-week move -5.2%.
Indicator stack
90/54
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.97%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
15 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 6.1% above the Trend Line and sits at 74.1% of its 52-week range. The latest completed week returned -0.9%, after a -5.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7312-week average 0.61
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.73Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.2% over four weeks, -2.6% over 12 weeks, and 58.1% over one year. The current trend has remained active for 13 consecutive weeks.
Performance by holding period
Active trend streak13 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.43Latest activity-pressure read.
Pressure change-48.2%Four-week change in activity pressure.
Leadership11.08Latest relative-leadership reading.
RS change-18.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 15 relevant articles.
2 positive · 11 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.1%Distance below the 52-week high.
13-week volatility2.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
3 Apr
1 May
29 May
26 Jun
24 Jul
21 Aug
25 Sep
Weeks higher14 of 2612 weeks finished lower.
Best week+7.6%Week of 12 Jun.
Worst week-5.5%Week of 8 May.
Latest week-0.9%Week of 25 Sep.
Shape of recent returns
Strong gains6
Modest gains8
Flat weeks0
Modest losses9
Sharp losses3
Recent vol2.5%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAR Healthcare
4-week rank17 / 20
Group average-0.7%
Trend breadth65.0%
Trend65.0%active weekly trend signals
MD70.0%positive activity pressure
RS70.0%positive relative leadership
Four-week leaders
IndustryAR Medical Distribution
4-week rank1 / 1
Group average-5.2%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis85/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.73; 1 reversal markers Next-Week ExpectancyPositive 55.97%Next-week expectancy is positive with a 55.97% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 15 relevant articles.
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 25 Sep 2026 | 118,925.00 ARS | -0.9% | 112,075.40 ARS | 67,720.01 ARS | 0.43 | 11.08 | 319 | On |
| 18 Sep 2026 | 120,025.00 ARS | -3.8% | 111,824.56 ARS | 67,109.59 ARS | 0.81 | 7.31 | 1.8K | On |
| 11 Sep 2026 | 124,800.00 ARS | -4.4% | 111,410.39 ARS | 66,484.10 ARS | 0.97 | 8.44 | 1.7K | On |
| 4 Sep 2026 | 130,600.00 ARS | 4.1% | 110,844.55 ARS | 65,823.71 ARS | 0.94 | 15.19 | 1.7K | On |
| 28 Aug 2026 | 125,400.00 ARS | 3.0% | 110,274.54 ARS | 65,127.11 ARS | 0.83 | 13.67 | 217 | On |
| 21 Aug 2026 | 121,800.00 ARS | -1.2% | 109,642.87 ARS | 64,466.84 ARS | 0.77 | 13.41 | 42 | On |
| 14 Aug 2026 | 123,300.00 ARS | -1.4% | 109,126.20 ARS | 63,831.43 ARS | 0.76 | 14.11 | 38 | On |
| 7 Aug 2026 | 125,000.00 ARS | 3.6% | 108,606.19 ARS | 63,176.66 ARS | 0.73 | 11.14 | 1.4K | On |
| 31 Jul 2026 | 120,650.00 ARS | -0.7% | 107,877.02 ARS | 62,493.14 ARS | 0.63 | 1.14 | 8 | On |
| 24 Jul 2026 | 121,550.00 ARS | 1.2% | 107,366.18 ARS | 61,835.07 ARS | 0.70 | 2.43 | 15 | On |
| 17 Jul 2026 | 120,075.00 ARS | -1.9% | 106,979.50 ARS | 61,162.49 ARS | 0.76 | 4.18 | 3 | On |
| 10 Jul 2026 | 122,350.00 ARS | 0.2% | 106,443.66 ARS | 60,499.31 ARS | 0.77 | 3.80 | 8 | On |
| 3 Jul 2026 | 122,050.00 ARS | 0.4% | 105,702.81 ARS | 59,823.23 ARS | 0.58 | 6.44 | 308 | On |
| 26 Jun 2026 | 121,599.06 ARS | 3.4% | 104,974.47 ARS | 59,143.93 ARS | 0.19 | 8.82 | 73 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.